Author Page for Saranath Lawpoolsri Niyom

Non-Inferiority Phase 2 Immunogenicity and Safety Study of 'Comvigen': A Model for Mrna Vaccine Development in Low- and Middle-Income Countries (LMICs)

Number of pages: 42 Posted: 28 Feb 2025

Chulalongkorn University - Thai Red Cross Emerging Infectious Diseases Clinical Centre, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, Thai Red Cross AIDS Research Centre, Bangkok, Chulalongkorn University, Chulalongkorn University, Chulalongkorn University, Armed Forces Research Institute of Medical Sciences, Mahidol University, Chulalongkorn University, National Center for Genetic Engineering and Biotechnology, Chulalongkorn University, Chulalongkorn University, Mahidol University, University of Pennsylvania - Department of Microbiology, University of Pennsylvania, Genevant Sciences Corporation, Genevant Sciences GmbH, BioNet-Asia Co Ltd, Chulalongkorn University and Independent

Downloads 120 (600,462)

Abstract:

2.

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial

Number of pages: 41 Posted: 15 Mar 2023

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri Niyom, Anan Jongkaewwattana, Arunee Thitithanyanont, Viravarn Luvira, Pailinrut Chinwangso, Narumon Thanthamnu, Narisara Chantratita, Jacqueline Kyungah Lim, T. Anh Wartel, Jean-Louis Excler, Martin F. Ryser, Chloe Leong, Tippi K. Mak and Punnee Pitisutthithum

Mahidol University - Vaccine Trial Centre, Phaholpolpayuhasena Hospital, Thammasat University, Mahidol University, Mahidol University, National Center for Genetic Engineering and Biotechnology, Mahidol University, Mahidol University, Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), Mahidol University, Mahidol University - Faculty of Tropical Medicine, International Vaccine Institute, International Vaccine Institute, International Vaccine Institute, Janssen Global Medical Affairs, Janssen Asia Pacific Medical Affairs Operations, National University of Singapore (NUS) - Duke-NUS Medical School and Mahidol University - Vaccine Trial Centre

Downloads 60 (970,490)

Abstract:

3.

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine

Number of pages: 28 Posted: 28 Mar 2025

Sant Muangnoicharoen, Saranath Lawpoolsri Niyom, Juthaporn Cowan, Viravarn Luvira, Anan Jongkaewwattana, Sira Nanthapisal, Weerapong Phumratanaprapin, Supitcha Kamolratakul, Narumon Thanthamnu, Chatnapa Duangdee and Punnee Pitisutthithum

Mahidol University - Vaccine Trial Centre, Mahidol University, Mahidol University, Mahidol University - Institute of Human Righs and Peace Studies, National Center for Genetic Engineering and Biotechnology, Thammasat University, Mahidol University, Mahidol University, Mahidol University, Mahidol University and Mahidol University - Vaccine Trial Centre

Downloads 48 (1,097,529)

Abstract:

4.

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S)

Number of pages: 30 Posted: 21 Jan 2025

Viravarn Luvira, Saranath Lawpoolsri Niyom, Weerapong Phumratanaprapin, Anan Jongkaewwattana, Sira Nanthapisal, Sant Muangnoicharoen, Supitcha Kamolratakul, Yupa Sabmee, Chatnapa Duangdee, Piengthong Narakorn, Surichan S, Laina Mercer, Rama Raghunandan, Christina Polyak, Ponthip Wirachwong, Jorge Flores and Punnee Pitisutthithum

Mahidol University - Institute of Human Righs and Peace Studies, Mahidol University, Mahidol University, National Center for Genetic Engineering and Biotechnology, Thammasat University, Mahidol University - Vaccine Trial Centre, Mahidol University, affiliation not provided to SSRN, Mahidol University, affiliation not provided to SSRN, affiliation not provided to SSRN, Institute for Disease Modeling, PATH, PATH, affiliation not provided to SSRN, PATH and Mahidol University - Vaccine Trial Centre

Downloads 45 (1,121,190)

Saranath Lawpoolsri Niyom

Mahidol University

4

273

0

Scholarly Papers (4)

Non-Inferiority Phase 2 Immunogenicity and Safety Study of 'Comvigen': A Model for Mrna Vaccine Development in Low- and Middle-Income Countries (LMICs)

Abstract:

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial

Abstract:

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine

Abstract:

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S)

Abstract: